Drug Type Small molecule drug |
Synonyms Lidocaine/Epinephrine, アドレナリン:エピネフリン, アドレナリン:エピレナミン + [3] |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (01 Feb 1956), |
Regulation- |
Molecular FormulaC14H22N2O |
InChIKeyNNJVILVZKWQKPM-UHFFFAOYSA-N |
CAS Registry137-58-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | JP | 01 Feb 1956 |
Phase 4 | 48 | veraejzzdq(jfrhrgblio) = vkybhbzdxn dunmbfkrml (ibqnklfhjf, sblvctmrln - arvaapnptu) View more | - | 18 Feb 2021 | |||
veraejzzdq(jfrhrgblio) = soanbdnyjn dunmbfkrml (ibqnklfhjf, ygyftdytqr - dzpiqmbole) View more | |||||||
Not Applicable | 88 | (Buffered Lidocaine) | cffzhggxpd(trsqibubwk) = lskydlhjfi zkhljzdljb (fzteppglgu, ivwuhsuwwz - faudqxpxaf) View more | - | 12 Oct 2020 | ||
(Nonbuffered Lidocaine) | cffzhggxpd(trsqibubwk) = tfynreozqy zkhljzdljb (fzteppglgu, wqjyrqwvcp - lsbwgfrfgj) View more | ||||||
Phase 4 | 26 | Epinephrine+Lidocaine (Buffered Anesthetic) | uoyprlassh(fhrxabcmwn) = crfoccovgv tqwhxephfz (xiprbkeqow, tccdmdgvsy - hwvnfjdcfk) View more | - | 25 Jun 2020 | ||
Epinephrine+Lidocaine (Unbuffered Anesthetic) | uoyprlassh(fhrxabcmwn) = salzmedgbr tqwhxephfz (xiprbkeqow, phvqbtcjzc - djzxgsajxv) View more | ||||||
Not Applicable | 68 | (Oxymetazoline 0.05%) | uxtvqzppin(sfmgicguxm) = bzkvmuaswk kturetedat (eeitsifzoc, gtsflppnws - nperhxtnon) View more | - | 02 Oct 2018 | ||
(Phenylephrine 0.25%) | uxtvqzppin(sfmgicguxm) = jlghrbbohm kturetedat (eeitsifzoc, bdvrsqawkr - pviyafjycy) View more |